Description:

CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747 Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3410554E-9E96-2D64-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3410554E-9E96-2D64-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 9/19/12
  2. 1/9/15
  3. 6/18/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink. Mark an X in the appropriate box for fields with a choice

Header
Are data amended
Patient demographics
Header
Biopsy specimen
Leukemia Classification (Mark one with an X.)
Has the patient developed progression of MDS to Acute Myelogenous Leukemia (AML)
Clinical Onset of AML (Mark one with an X.)
Source of Cells used for Analysis (Specimens must be submitted within one week of date sample obtained. Mark one with an X.)
Sample Period (Mark one with an X.)
Required document types (Mark all that apply with an X.)
Contact information
Footer module

Similar models